Entremed (ENMD)

[tborges]

These types of conferences are targeting the researchers, providing information on ongoing research and new directions...the emphasis will be on what has been learned and what is to be learned... The patient populations in the 2076 trials have been small... it will take larger patient populations, usually in a P3 trial to validate the results that may be positive in the smaller trials...

I do believe that the presentation will be positive and will have some effect on the PPS... but again... I view this more as an update rather than a game changer... remember most of this data has already been reported/published.

The "blockbuster" news we are all looking for will come from the FDA in the form of approval...